All In MedTech

Device Trial Radar · NCT03900468

Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)

Last checked: Nov 20, 2026Latest source record: Apr 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

29

Actual

Start

Mar 5, 2020

Primary completion

Oct 15, 2025

Study completion Feb 26, 2026

Sponsor

Lead sponsor
MedtronicNeuroNot on our public-company list
Sponsor type
Industry
First posted
Apr 3, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.

Conditions

  • Epilepsy

Interventions

  • Activa™ PC and Percept™ PC Neurostimulation SystemsDevice

    Implanted DBS system consisting of a Neurostimulator, Leads, Extensions, and potential accessories including Burr Hole Devices, Clinician Tablet, Clinician Programmer Therapy Application Software, Clinician Programmer Communicator, Patient Programmer

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage Reduction in Total Seizure FrequencyTime frame: Pre-implant compared to 36 months post-implant

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California Los Angeles (UCLA)

    Los Angeles, California

  • University of California San Francisco UCSF Medical Center

    San Francisco, California

  • Emory University Hospital

    Atlanta, Georgia

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.